Useful Management Information

The TOBI podhaler containing tobramycin powder for inhalation is a bacterial antibiotic used to treat Pseudomonas aeruginosa infections in patients with cystic fibrosis.

Indications:
Before using TOBI podhaler, the patient must be assessed for bronchial hyperresponsiveness.

Contraindications:

  • Do not perform in patients who are hypersensitive to tobramycin, any of the inactive ingredients (1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC], calcium chloride, and sulphuric acid for pH adjustment) or to any other aminoglycoside antibacterial.
  • Acute myocardial infarction within 1 week.
  • Systemic hypotension or severe hypertension.
  • Significant atrial/ventricular arrhythmia.
  • Non-compensated heart failure.
  • Uncontrolled pulmonary hypertension.
  • Acute cor pulmonale.
  • Clinically unstable pulmonary embolism.
  • History of syncope related to forced expiration/cough.
  • Cerebral aneurysm.
  • Brain surgery within 4 weeks.
  • Recent concussion with continuing symptoms.
  • Eye surgery within 1 week.
  • Sinus surgery or middle ear surgery or infection within 1 week.
  • Presence of pneumothorax.
  • Thoracic surgery within 4 weeks.
  • Abdominal surgery within 4 weeks.
  • Late term pregnancy.
  • Active or suspected transmissible respiratory or systemic infection including tuberculosis.
  • Physical conditions predisposing to transmission of infections.

The safety and effectiveness of the TOBI podhaler has not been established in patients:

  • With an FEV1 <25% and >80% predicted.
  • With auditory or vestibular dysfunction.
  • With renal dysfunction.
  • With neuromuscular dysfunction.
  • With hepatic impairment.
  • Patients under 6 years of age and over 65 years of age.
  • Who have had organ transplantation.
  • Who are pregnant or breastfeeding.
  • Who are colonized with Burkholderia cepacia.

Minimum Referral Criteria

Does your patient meet the minimum referral criteria?
Category Category 1 ((appointment within 30 calendar days))
  • Requires tests within 30 days.
Category Category 2 ((appointment within 90 calendar days))
  • Requires tests within 90 days.
Category Category 3 ((appointment within 365 calendar days))
  • Requires tests within 365 days.

If your patient does not meet the minimum referral criteria

  • Assessment and management information may be found on a range of conditions at HealthPathways
  • If the patient does not meet the criteria for referral but the referring practitioner believes the patient requires specialist review, a clinical override may be requested:
    • Please explain why (e.g. warning signs or symptoms, clinical modifiers, uncertain about diagnosis, etc.)
  • Please note that your referral may not be accepted or may be redirected to another service

Essential Referral Information

  • Reason for referral - what is the clinical question to be answered by performing the test?
  • Current respiratory medications.
  • Infectious status.

If a specific test result is unable to be obtained due to access, financial, religious, cultural or consent reasons a Clinical Override may be requested. This reason must be clearly articulated in the body of the referral.

Additional Referral Information

  • No additional referral information
Last updated 19 August 2021

Send Referrals To

Smart Referrals

Not Available

Secure Web Transfer

Not Available

Internal Referrals

Lung Function Lab (E-Blueslips)

Fax

(07) 5687 7894

Post

Lung Function Lab
Gold Coast University Hospital
1 Hospital Boulevard
Southport QLD 4215

Enquiries

(07) 5687 4497

Related HealthPathways

No directly related pathways found

Service Availability

Dr Carl Pahoff
Medical Director Respiratory - Lung Function Laboratory, and Pulmonary Function Tests

Facilities

Gold Coast University Hospital
Robina Hospital

If you would like to send a named referral, please address it to the specialist listed above, who will allocate a suitably qualified specialist to see the patient. Alternatively, you can view a full list of our specialists.

Gold Coast Health - For Clinicians
© The State of Queensland 1995-2021 | Queensland Government
Queensland Government acknowledges the Traditional Owners of the land and pays respect to Elders past, present and future.